Evaluation of Possible Proarrhythmic Potency

Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native i Kr Currents and on Cardiac Action Potential

Péter Orvos, Zsófia Kohajda, Jozefina Szlovák, Péter Gazdag, Tamás Árpádffy-Lovas, Dániel Tóth, Amir Geramipour, László Tálosi, N. Jost, A. Varró, L. Virág

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The proarrhythmic potency of drugs is usually attributed to the I Kr current block. During safety pharmacology testing analysis of I Kr in cardiomyocytes was replaced by human ether-a-go-go-related gene (hERG) test using automated patch-clamp systems in stable transfected cell lines. Aim of this study was to compare the effect of proarrhythmic compounds on hERG and I Kr currents and on cardiac action potential. The hERG current was measured by using both automated and manual patch-clamp methods on HEK293 cells. The native ion currents (I Kr, I NaL, I CaL) were recorded from rabbit ventricular myocytes by manual patch-clamp technique. Action potentials in rabbit ventricular muscle and undiseased human donor hearts were studied by conventional microelectrode technique. Dofetilide, cisapride, sotalol, terfenadine, and verapamil blocked hERG channels at 37°C with an IC 50 of 7 nM, 18 nM, 343 μM, 165 nM, and 214 nM, respectively. Using manual patch-clamp, the IC 50 values of sotalol and terfenadine were 78 μM and 31 nM, respectively. The IC 50 values calculated from I Kr measurements at 37°C were 13 nM, 26 nM, 52 μM, 54 nM, and 268 nM, respectively. Cisapride, dofetilide, and sotalol excessively lengthened, terfenadine, and verapamil did not influence the action potential duration. Terfenadine significantly inhibited I NaL and moderately I CaL, verapamil blocked only I CaL. Automated hERG assays may over/underestimate proarrhythmic risk. Manual patch-clamp has substantially higher sensitivity to certain drugs. Action potential studies are also required to analyze complex multichannel effects. Therefore, manual patch-clamp and action potential experiments should be a part of preclinical safety tests.

Original languageEnglish
Pages (from-to)365-380
Number of pages16
JournalToxicological Sciences
Volume168
Issue number2
DOIs
Publication statusPublished - Apr 1 2019

Fingerprint

Terfenadine
Cisapride
Sotalol
Clamping devices
Verapamil
Ether
Action Potentials
Genes
Safety testing
Rabbits
Safety
HEK293 Cells
Microelectrodes
Patch-Clamp Techniques
Cardiac Myocytes
Pharmaceutical Preparations
Muscle Cells
Muscle
dofetilide
Assays

Keywords

  • cardiac action potential
  • hERG
  • I Kr
  • proarrhythmia
  • safety pharmacology

ASJC Scopus subject areas

  • Toxicology

Cite this

Evaluation of Possible Proarrhythmic Potency : Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native i Kr Currents and on Cardiac Action Potential. / Orvos, Péter; Kohajda, Zsófia; Szlovák, Jozefina; Gazdag, Péter; Árpádffy-Lovas, Tamás; Tóth, Dániel; Geramipour, Amir; Tálosi, László; Jost, N.; Varró, A.; Virág, L.

In: Toxicological Sciences, Vol. 168, No. 2, 01.04.2019, p. 365-380.

Research output: Contribution to journalArticle

Orvos, Péter ; Kohajda, Zsófia ; Szlovák, Jozefina ; Gazdag, Péter ; Árpádffy-Lovas, Tamás ; Tóth, Dániel ; Geramipour, Amir ; Tálosi, László ; Jost, N. ; Varró, A. ; Virág, L. / Evaluation of Possible Proarrhythmic Potency : Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native i Kr Currents and on Cardiac Action Potential. In: Toxicological Sciences. 2019 ; Vol. 168, No. 2. pp. 365-380.
@article{9b18895a065b4b1b94bda47a4518fa48,
title = "Evaluation of Possible Proarrhythmic Potency: Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native i Kr Currents and on Cardiac Action Potential",
abstract = "The proarrhythmic potency of drugs is usually attributed to the I Kr current block. During safety pharmacology testing analysis of I Kr in cardiomyocytes was replaced by human ether-a-go-go-related gene (hERG) test using automated patch-clamp systems in stable transfected cell lines. Aim of this study was to compare the effect of proarrhythmic compounds on hERG and I Kr currents and on cardiac action potential. The hERG current was measured by using both automated and manual patch-clamp methods on HEK293 cells. The native ion currents (I Kr, I NaL, I CaL) were recorded from rabbit ventricular myocytes by manual patch-clamp technique. Action potentials in rabbit ventricular muscle and undiseased human donor hearts were studied by conventional microelectrode technique. Dofetilide, cisapride, sotalol, terfenadine, and verapamil blocked hERG channels at 37°C with an IC 50 of 7 nM, 18 nM, 343 μM, 165 nM, and 214 nM, respectively. Using manual patch-clamp, the IC 50 values of sotalol and terfenadine were 78 μM and 31 nM, respectively. The IC 50 values calculated from I Kr measurements at 37°C were 13 nM, 26 nM, 52 μM, 54 nM, and 268 nM, respectively. Cisapride, dofetilide, and sotalol excessively lengthened, terfenadine, and verapamil did not influence the action potential duration. Terfenadine significantly inhibited I NaL and moderately I CaL, verapamil blocked only I CaL. Automated hERG assays may over/underestimate proarrhythmic risk. Manual patch-clamp has substantially higher sensitivity to certain drugs. Action potential studies are also required to analyze complex multichannel effects. Therefore, manual patch-clamp and action potential experiments should be a part of preclinical safety tests.",
keywords = "cardiac action potential, hERG, I Kr, proarrhythmia, safety pharmacology",
author = "P{\'e}ter Orvos and Zs{\'o}fia Kohajda and Jozefina Szlov{\'a}k and P{\'e}ter Gazdag and Tam{\'a}s {\'A}rp{\'a}dffy-Lovas and D{\'a}niel T{\'o}th and Amir Geramipour and L{\'a}szl{\'o} T{\'a}losi and N. Jost and A. Varr{\'o} and L. Vir{\'a}g",
year = "2019",
month = "4",
day = "1",
doi = "10.1093/toxsci/kfy299",
language = "English",
volume = "168",
pages = "365--380",
journal = "Toxicological Sciences",
issn = "1096-6080",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Evaluation of Possible Proarrhythmic Potency

T2 - Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native i Kr Currents and on Cardiac Action Potential

AU - Orvos, Péter

AU - Kohajda, Zsófia

AU - Szlovák, Jozefina

AU - Gazdag, Péter

AU - Árpádffy-Lovas, Tamás

AU - Tóth, Dániel

AU - Geramipour, Amir

AU - Tálosi, László

AU - Jost, N.

AU - Varró, A.

AU - Virág, L.

PY - 2019/4/1

Y1 - 2019/4/1

N2 - The proarrhythmic potency of drugs is usually attributed to the I Kr current block. During safety pharmacology testing analysis of I Kr in cardiomyocytes was replaced by human ether-a-go-go-related gene (hERG) test using automated patch-clamp systems in stable transfected cell lines. Aim of this study was to compare the effect of proarrhythmic compounds on hERG and I Kr currents and on cardiac action potential. The hERG current was measured by using both automated and manual patch-clamp methods on HEK293 cells. The native ion currents (I Kr, I NaL, I CaL) were recorded from rabbit ventricular myocytes by manual patch-clamp technique. Action potentials in rabbit ventricular muscle and undiseased human donor hearts were studied by conventional microelectrode technique. Dofetilide, cisapride, sotalol, terfenadine, and verapamil blocked hERG channels at 37°C with an IC 50 of 7 nM, 18 nM, 343 μM, 165 nM, and 214 nM, respectively. Using manual patch-clamp, the IC 50 values of sotalol and terfenadine were 78 μM and 31 nM, respectively. The IC 50 values calculated from I Kr measurements at 37°C were 13 nM, 26 nM, 52 μM, 54 nM, and 268 nM, respectively. Cisapride, dofetilide, and sotalol excessively lengthened, terfenadine, and verapamil did not influence the action potential duration. Terfenadine significantly inhibited I NaL and moderately I CaL, verapamil blocked only I CaL. Automated hERG assays may over/underestimate proarrhythmic risk. Manual patch-clamp has substantially higher sensitivity to certain drugs. Action potential studies are also required to analyze complex multichannel effects. Therefore, manual patch-clamp and action potential experiments should be a part of preclinical safety tests.

AB - The proarrhythmic potency of drugs is usually attributed to the I Kr current block. During safety pharmacology testing analysis of I Kr in cardiomyocytes was replaced by human ether-a-go-go-related gene (hERG) test using automated patch-clamp systems in stable transfected cell lines. Aim of this study was to compare the effect of proarrhythmic compounds on hERG and I Kr currents and on cardiac action potential. The hERG current was measured by using both automated and manual patch-clamp methods on HEK293 cells. The native ion currents (I Kr, I NaL, I CaL) were recorded from rabbit ventricular myocytes by manual patch-clamp technique. Action potentials in rabbit ventricular muscle and undiseased human donor hearts were studied by conventional microelectrode technique. Dofetilide, cisapride, sotalol, terfenadine, and verapamil blocked hERG channels at 37°C with an IC 50 of 7 nM, 18 nM, 343 μM, 165 nM, and 214 nM, respectively. Using manual patch-clamp, the IC 50 values of sotalol and terfenadine were 78 μM and 31 nM, respectively. The IC 50 values calculated from I Kr measurements at 37°C were 13 nM, 26 nM, 52 μM, 54 nM, and 268 nM, respectively. Cisapride, dofetilide, and sotalol excessively lengthened, terfenadine, and verapamil did not influence the action potential duration. Terfenadine significantly inhibited I NaL and moderately I CaL, verapamil blocked only I CaL. Automated hERG assays may over/underestimate proarrhythmic risk. Manual patch-clamp has substantially higher sensitivity to certain drugs. Action potential studies are also required to analyze complex multichannel effects. Therefore, manual patch-clamp and action potential experiments should be a part of preclinical safety tests.

KW - cardiac action potential

KW - hERG

KW - I Kr

KW - proarrhythmia

KW - safety pharmacology

UR - http://www.scopus.com/inward/record.url?scp=85063712535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063712535&partnerID=8YFLogxK

U2 - 10.1093/toxsci/kfy299

DO - 10.1093/toxsci/kfy299

M3 - Article

VL - 168

SP - 365

EP - 380

JO - Toxicological Sciences

JF - Toxicological Sciences

SN - 1096-6080

IS - 2

ER -